Tornhammar P, Julner A, Al Moosawi N, Wicksell E, Lim C, Andersson D
BMJ Open. 2024; 14(11):e085906.
PMID: 39542470
PMC: 11575289.
DOI: 10.1136/bmjopen-2024-085906.
Lipworth W, Kerridge I, Stewart C, Silva D, Upshur R
J Bioeth Inq. 2023; 20(4):607-616.
PMID: 38064166
DOI: 10.1007/s11673-023-10289-w.
Lora D, Garcia-Reyne A, Lalueza A, Maestro de la Calle G, Ruiz-Ruigomez M, Calderon E
Front Public Health. 2023; 11:1171975.
PMID: 37841720
PMC: 10569070.
DOI: 10.3389/fpubh.2023.1171975.
Silva P, Janjan N, Ramos K, Udeani G, Zhong L, Ory M
Front Med (Lausanne). 2023; 10:1198088.
PMID: 37484840
PMC: 10359981.
DOI: 10.3389/fmed.2023.1198088.
Georgiadi E, Sachlas A
Stat Biosci. 2023; 15(2):384-396.
PMID: 37313549
PMC: 10019791.
DOI: 10.1007/s12561-023-09366-w.
Adaptive, platform trials assessing therapies for hospitalized COVID-19 patients: Informed consent forms omitted a few important elements of information.
Dal-Re R, Voo T, Holm S
J Glob Health. 2023; 13:06019.
PMID: 37166268
PMC: 10173897.
DOI: 10.7189/jogh.13.06019.
Disparities in COVID-19 clinical studies from high-income and low-and middle-income countries.
Yin S, Ren J, Xue J, Li P, Luo J, Yin J
Int J Infect Dis. 2023; 132:9-16.
PMID: 37068582
PMC: 10105623.
DOI: 10.1016/j.ijid.2023.04.393.
ESC working group on e-cardiology position paper: use of commercially available wearable technology for heart rate and activity tracking in primary and secondary cardiovascular prevention-in collaboration with the European Heart Rhythm Association,....
Jensen M, Treskes R, Caiani E, Casado-Arroyo R, Cowie M, Dilaveris P
Eur Heart J Digit Health. 2023; 2(1):49-59.
PMID: 36711174
PMC: 9753086.
DOI: 10.1093/ehjdh/ztab011.
Estimating the effect of COVID-19 on trial design characteristics: a registered report.
Smith J, DeVito N, Lee H, Tiplady C, Abhari R, Kartsonaki C
R Soc Open Sci. 2023; 10(1):201543.
PMID: 36686547
PMC: 9832295.
DOI: 10.1098/rsos.201543.
Adverse effect signature extraction and prediction for drugs treating COVID-19.
Wang H, Wang X, Li T, Lai D, Zhang Y
Front Genet. 2022; 13:1019940.
PMID: 36406131
PMC: 9673014.
DOI: 10.3389/fgene.2022.1019940.
Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data.
Jang H, Kim I, Oh J
Front Pharmacol. 2022; 13:928121.
PMID: 36110539
PMC: 9468970.
DOI: 10.3389/fphar.2022.928121.
Public health research priorities for WHO on COVID-19 in the South-East Asia Region: results of a prioritization survey.
Azim T, Bhushan A, Del Rio Vilas V, Srivastava R, Wijesinghe P, Ofrin R
Health Res Policy Syst. 2022; 20(1):96.
PMID: 36064411
PMC: 9443619.
DOI: 10.1186/s12961-022-00862-x.
Drugs and convalescent plasma therapy for COVID-19: a survey of the interventional clinical studies in Italy after 1 year of pandemic.
Puopolo M, Morciano C, Buoncervello M, De Nuccio C, Potenza R, Toschi E
Trials. 2022; 23(1):527.
PMID: 35733167
PMC: 9214678.
DOI: 10.1186/s13063-022-06474-8.
Randomized controlled trials in patients with COVID-19: a systematic review and critical appraisal.
Kudhail K, Thompson J, Mathews V, Morrison B, Hemming K
Int J Infect Dis. 2022; 122:72-80.
PMID: 35597556
PMC: 9113951.
DOI: 10.1016/j.ijid.2022.05.034.
Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19: meta-epidemiological study.
Moneer O, Daly G, Skydel J, Nyhan K, Lurie P, Ross J
BMJ. 2022; 377:e069400.
PMID: 35537738
PMC: 9086409.
DOI: 10.1136/bmj-2021-069400.
Choosing Wisely in clinical practice: Embracing critical thinking, striving for safer care.
Furlan L, Di Francesco P, Costantino G, Montano N
J Intern Med. 2022; 291(4):397-407.
PMID: 35307902
PMC: 9314697.
DOI: 10.1111/joim.13472.
Letter to the Editor: "The impact of COVID-19 pandemic on the initiation of interventional clinical trials conducted in intensive care units".
Huang C, Gao S, Barwise A, Lai X, Huang W, Xiao Y
J Crit Care. 2022; 69:154019.
PMID: 35290933
PMC: 8917824.
DOI: 10.1016/j.jcrc.2022.154019.
Characterising COVID-19 empirical research production in Latin America and the Caribbean: A scoping review.
Mansilla C, Herrera C, Boeira L, Yearwood A, Lopez A, Colunga-Lozano L
PLoS One. 2022; 17(2):e0263981.
PMID: 35171957
PMC: 8849471.
DOI: 10.1371/journal.pone.0263981.
How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials.gov.
Hutchinson N, Klas K, Carlisle B, Kimmelman J, Waligora M
PLoS One. 2022; 17(1):e0262114.
PMID: 35061758
PMC: 8782516.
DOI: 10.1371/journal.pone.0262114.
A Call for Quality: Substandard Research in Male Sexual and Reproductive Medicine During the COVID-19 Pandemic.
Pastuszak A, Patel D, Jenkins L, Hsieh T, Yafi F, Mumford S
J Sex Med. 2021; 19(1):1-4.
PMID: 34844887
PMC: 8556583.
DOI: 10.1016/j.jsxm.2021.10.003.
